Co-crystal Screening
Choose suitable co-formers to design experiments; Co-crystal form identification and characterization; Thermodynamic phase relationship study; Stability and solubility evaluation; Co-crystal form recommendation.
Explore co-crystal, salt, and polymorph screening to understand and optimize the solid-state properties of your compounds.
The science
We provide co-crystal, salt, and polymorph screening to identify, characterize, and select the optimal crystal form of Active Pharmaceutical Ingredients (APIs). These platforms enhance drug solubility, stability, and bioavailability, and support intellectual property (IP) protection and regulatory compliance. Selecting the optimal solid form of an API during early drug development can mitigate the risk of failure later in development. Our expert R&D team provides specialized consulting and laboratory services to guide these processes from discovery through clinical phases.
How we can help
Explore the services and methods available for your project.
Choose suitable co-formers to design experiments; Co-crystal form identification and characterization; Thermodynamic phase relationship study; Stability and solubility evaluation; Co-crystal form recommendation.
Design various salt-forming experiments according to the physicochemical properties of compound; Salt form identification and characterization; Thermodynamic phase relationship study; Stability and solubility evaluation; Salt type selection and salt form recommendation.
Design various crystallization conditions according to the physicochemical properties of compound; Crystal form identification and characterization; Thermodynamic phase relationship study; Stability and solubility evaluation; Optimal solid form recommendation.
How a project runs
4 stages, with a clear outcome at each step.
Designing co-crystal, salt, or polymorph screening conditions based on API physicochemical properties.
Outcome: Screening Matrix
Executing crystallization screens (Crystal16) and identifying crystalline forms via PXRD, DSC, TGA, and Raman/FT-IR.
Outcome: Form Identification
Evaluating thermodynamic phase relationships, solubility profiles, and DVS hygroscopicity.
Outcome: Thermodynamic Stability
Recommending the optimal solid form for development and providing data packages for IP protection and regulatory compliance.
Outcome: Optimal Form Nomination
Explore in detail
Open a section to explore our full service scope and instrumentation.
Identify and select optimal crystal forms to significantly enhance drug solubility, dissolution rates, and in-vivo bioavailability.
Secure solid-state IP boundaries through novel co-crystal, salt, and polymorph form identification and recommendation.
Mitigate the risk of solid-state phase transformation failures early in drug discovery through specialized screening.
Comprehensive thermodynamic phase relationship studies, hygroscopicity testing, and long-term stability evaluation.
Let’s work together
Talk with our scientific team about your requirements,
technical feasibility, and timelines.